Breaking |

Breaking |

Mumbai Hospital begins trial of Covishield vaccine
Published : Sep 23, 2020, 3:28 pm IST
Updated : Sep 23, 2020, 3:28 pm IST
SHARE ARTICLE
Covid-19 vaccine
Covid-19 vaccine

The civic-run King Edward Memorial (KEM) Hospital in Mumbai on Wednesday began phase II and III trials of the Oxford Covishield vaccine

Mumbai: The civic-run King Edward Memorial (KEM) Hospital in Mumbai on Wednesday began phase II and III trials of the Oxford Covishield vaccine for Covid-19, an official said.

The hospital, on Tuesday got the approval of the Maharashtra ethics committee for conducting the vaccine trials.

Advertisement

Covid-19 vaccineCovid-19 vaccineKEM Hospital Dean Dr Hemant Deshmukh said that the hospital has started screening volunteers for the trials.

The medical facility will be conducting the trials on 100 volunteers, he said.

The city-based B Y L Nair Hospital, another facility run by the Brihanmumbai Municipal Corporation, has also received approval for conducting trials of the vaccine.

Advertisement

Covid-19 vaccineCovid-19 vaccineBoth the KEM and Nair hospitals will be conducting the trials collectively on over 200 volunteers, sources said.

As part of the trials, volunteers who are found negative for coronavirus in both RT-PCR and antigen tests will be given the vaccine, they said.

Advertisement

SHARE ARTICLE

ROZANA SPOKESMAN

Advertisement

Good News Amid Gas-Oil Crisis: Crude Oil Ship Arrives in Mumbai

12 Mar 2026 5:44 PM

Anmol Gagan Mann Slams Political Parties for Drug Menace, Punjab Under Fire

10 Mar 2026 6:23 PM

Hoshiarpur: \'Open the shutters, we will go home too\', attackers entered with weapons, people from outside closed the shutters

10 Mar 2026 6:19 PM

The entire Congress insults our women - Minister Harpal Cheema

10 Mar 2026 6:17 PM

Punjab Budget 2026 : Rs 1,000 per month for women under \'Mukh Mantri Mawan Dhiyan Satkar Yojana

08 Mar 2026 5:04 PM

Grand final clash today in the T20 World Cup; the cricket teams of India and New Zealand will face each other

08 Mar 2026 5:01 PM
Advertisement